Abstract
Nontuberculous mycobacteria (NTM) refer to mycobacteria other than Mycobacterium tuberculosis (MTB) and M. leprae. The incidence and prevalence of NTM Lung disease (NTM-LD) is rising worldwide and accounts for most of clinical cases. NTM infections occur both in immunocompetent and immunocompromised hosts. The diagnosis is based on an association of clinical, microbiological and radiological criteria. NTM lung disease treatment is challenging due to long, complicated, and difficult to tolerate antibiotic regimens. Clinicians should be aware of the aspects of NTM lung disease, including the need for accurate diagnosis, the availability of advanced molecular genotyping to identify the species, and the benefits and limitations of recommended treatments.
| Original language | English (US) |
|---|---|
| Title of host publication | Nontuberculous Mycobacteria (NTM) |
| Subtitle of host publication | Microbiological, Clinical and Geographical Distribution |
| Publisher | Elsevier |
| Pages | 121-132 |
| Number of pages | 12 |
| ISBN (Electronic) | 9780128146934 |
| ISBN (Print) | 9780128146927 |
| DOIs | |
| State | Published - Jan 16 2019 |
| Externally published | Yes |
Keywords
- Clinical manifestations
- Diagnosis
- Lung disease
- M abscesses
- MAI
- Management
- NTM
- Non-tuberculous mycobacteria
ASJC Scopus subject areas
- Agricultural and Biological Sciences(all)
- Biochemistry, Genetics and Molecular Biology(all)